A 26-week diabetes study measured human activity at 1 mg, but its endpoint was blood sugar rather than long-term weight. A short outpatient cohort measured about 4.7% weight loss over four weeks at 2.5 mg. Below 1 mg, estimates rely on pharmacokinetics and mechanism
MGF supports targeted muscle growth and repair, making it valuable for patients looking to improve specific muscle groups or address imbalances
It's not the B12 causing the gain, but the lack of B12 impairing your body's ability to maintain its usual energy output
This shift can affect barrier function, inflammatory balance, and gutbrain signaling.*1-3
That can lead to loss of control of body movements
A post-absorptive state ensures digestive demands are not competing with the peptides cellular signaling, allowing for cleaner mitochondrial activation